Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor–Negative Breast Cancer Chemoprevention

MLA

Fatma Nihan Akkoc Mustafayev, et al. “Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor–Negative Breast Cancer Chemoprevention.” European Journal of Breast Health, vol. 19, no. 4, Oct. 2023, pp. 267–73. EBSCOhost, https://doi.org/10.4274/ejbh.galenos.2023.2023-7-3.

APA

Fatma Nihan Akkoc Mustafayev, Diane D. Liu, Angelica M. Gutierrez, John E. Lewis, Nuhad K. Ibrahim, Vicente Valero, Daniel J. Booser, Jennifer K. Litton, Kimberly Koenig, Dihua Yu, Nour Sneige, & Banu K. Arun. (2023). Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor–Negative Breast Cancer Chemoprevention. European Journal of Breast Health, 19(4), 267–273. https://doi.org/10.4274/ejbh.galenos.2023.2023-7-3

Chicago

Fatma Nihan Akkoc Mustafayev, Diane D. Liu, Angelica M. Gutierrez, John E. Lewis, Nuhad K. Ibrahim, Vicente Valero, Daniel J. Booser, et al. 2023. “Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor–Negative Breast Cancer Chemoprevention.” European Journal of Breast Health 19 (4): 267–73. doi:10.4274/ejbh.galenos.2023.2023-7-3.